Invivyd (IVVD) EBT (QoQ) (2021 - 2025)
Invivyd (IVVD) EBT (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn |
| 10 | Invivyd | 104.45 Mn | -122.24 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.33% |
| Sep 30, 2025 | 23.18% |
| Jun 30, 2025 | 9.94% |
| Mar 31, 2025 | 7.57% |
| Dec 31, 2024 | 70.48% |
| Sep 30, 2024 | -26.30% |
| Jun 30, 2024 | 37.38% |
| Mar 31, 2024 | -4.04% |
| Dec 31, 2023 | -69.31% |
| Sep 30, 2023 | 17.07% |
| Jun 30, 2023 | -36.51% |
| Mar 31, 2023 | 17.82% |
| Dec 31, 2022 | 9.45% |
| Sep 30, 2022 | 8.95% |
| Jun 30, 2022 | 47.26% |
| Mar 31, 2022 | -33.67% |
| Dec 31, 2021 | 87.13% |
| Sep 30, 2021 | -429.48% |
| Jun 30, 2021 | -214.96% |